Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation Expense (Details)

v3.10.0.1
Stock-Based Compensation Expense (Details)
$ in Thousands
3 Months Ended 6 Months Ended 49 Months Ended
Sep. 30, 2018
USD ($)
shares
Sep. 30, 2017
USD ($)
Sep. 30, 2018
USD ($)
shares
Jun. 30, 2014
plan
Apr. 08, 2011
shares
Jul. 28, 2010
shares
Stock-Based Compensation Expense            
Number of stock option award plans | plan       2    
Options outstanding (in shares) 344,487   344,487      
Stock compensation expense | $ $ 1,085 $ 947        
Restricted Stock and Stock Option Plan            
Stock-Based Compensation Expense            
Maximum number of shares of the company's common stock that may be awarded           2,767,171
2011 Long-term Incentive Plan            
Stock-Based Compensation Expense            
Maximum number of shares of the company's common stock that may be awarded         2,893,341  
Restricted Stock Units            
Stock-Based Compensation Expense            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period     89,114      
Stock Issued During Period, Value, Restricted Stock Award, Gross | $     $ 2,098      
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period     3 years      
Common Stock            
Stock-Based Compensation Expense            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 5,240          
Stock Issued During Period, Value, Restricted Stock Award, Gross | $ $ 120          
Share-based compensation arrangement by share-based payment award, fair value of shares authorized amount | $ $ 420   $ 420      
Performance Shares            
Stock-Based Compensation Expense            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period     11,533      
Stock Issued During Period, Value, Restricted Stock Award, Gross | $     $ 320      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Fair Value | $     $ 0      
Minimum            
Stock-Based Compensation Expense            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Possible Number of Performance Shares to be Granted     0      
Maximum            
Stock-Based Compensation Expense            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Possible Number of Performance Shares to be Granted     23,066      
Management | Performance Shares            
Stock-Based Compensation Expense            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period     46,032      
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period     3 years      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Fair Value | $     $ 1,084      
Management | Minimum            
Stock-Based Compensation Expense            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Possible Number of Performance Shares to be Granted     0      
Management | Maximum            
Stock-Based Compensation Expense            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Possible Number of Performance Shares to be Granted     15,920      
Management | Maximum | Performance Shares            
Stock-Based Compensation Expense            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Possible Number of Performance Shares to be Granted     92,064      
Executive Officer | Performance Shares            
Stock-Based Compensation Expense            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 10,613